1-3 of 3
Adam J. Esbenshade
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Apixaban Is Effective and Safe in Reducing Venous Thromboembolism (VTE) in Obese Patients with Newly Diagnosed Pediatric Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma (ALL/LL) a Sub-Study Analysis of the Prevapix-ALL/Children's Oncology Group ACCL1333 Trial

Vilmarie Rodriguez, Sarah O'Brien, Glen Lew, Etan Orgel, Kimberly Derr, Mark A. Ranalli, Corinna L. Schultz, Adam J. Esbenshade, Arteid Memaj, Joshua Dyme, Nicholas Favatella, Lesley Mitchell
Journal: Blood
Blood (2023) 142 (Supplement 1): 810.
https://doi.org/10.1182/blood-2023-180037
Published: 2023
Journal Articles

Infectious Outcomes of Pediatric Acute Lymphoblastic Leukemia Patients Presenting with Non-Neutropenic Fever

Pratik A. Patel, MD, Nicholas P. DeGroote, MPH, Adam J. Esbenshade, MD MSc, William T. Cash, MDMSc, Sharon M. Castellino, MD MSc, Preeti Jaggi, MD, Tamara P. Miller, MDMSc
Journal: Blood
Blood (2020) 136 (Supplement 1): 33–34.
https://doi.org/10.1182/blood-2020-139421
Published: 2020
Journal Articles

High Prevalence of Metabolic Syndrome Traits in Children with Acute Lymphoblastic Leukemia Entering Maintenance Therapy.

Adam J. Esbenshade, MD, Tatsuki Koyama, PhD, Jill H. Simmons, MD, James A. Whitlock, MD, Debra L. Friedman, MD, MS
Journal: Blood
Blood (2009) 114 (22): 4114.
https://doi.org/10.1182/blood.V114.22.4114.4114
Published: 2009